Tag: Tumor
Share Skyrockets on news of positive early-stage results from GEN-009 Clinical...
Genocea Biosciences, Inc. (NASDAQ: GNCA) skyrocketed today based on news of promising data from its early stage clinical trials of GEN-009, its neoantigen vaccine candidate....
Can These Breakthrough Therapeutics win the fight against Mesothelioma?
An estimated 2,400 – 2,800 new incidence of Mesothelioma occurs each year in the U.S alone, according to an estimate by the Centers for...
We are looking for talented interns to learn and help investors find valuable companies.